Eylea

The latest news about Eylea: headlines, AI summaries and the full story from every source.

• Regeneron's Future May Depend on Dupixent Amid Eylea Sales Decline Motley Fool · October 17, 2026, 19:24 UTC
• Regeneron Exceeds Quarterly Estimates, Driven by Strong Sales of Eczema Drug Dupixent Yahoo Finance · July 30, 2026, 11:59 UTC